Holen Sie sich die Stockscreener-App
3.82
9.05%
-0.38
Vorhandelsmarkt:
3.82
Schlusskurs vom Vortag:
$4.20
Offen:
$4.15
24-Stunden-Volumen:
131.92K
Relative Volume:
0.05
Marktkapitalisierung:
$26.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.65M
KGV:
-0.8584
EPS:
-4.45
Netto-Cashflow:
$-20.83M
1W Leistung:
-15.67%
1M Leistung:
+81.90%
6M Leistung:
+124.71%
1J Leistung:
+45.80%
1-Tages-Spanne:
$3.7707
$4.35
1-Wochen-Bereich:
$3.7707
$4.80
52-Wochen-Spanne:
$1.15
$12.46
Minerva Neurosciences Inc Stock (NERV) Company Profile
Firmenname
Minerva Neurosciences Inc
Sektor
Branche
Telefon
617-600-7373
Adresse
1601 TRAPELO ROAD, WALTHAM, MA
Vergleichen Sie NERV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NERV
Minerva Neurosciences Inc
|
3.82 | 29.37M | 0 | -33.65M | -20.83M | -4.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Minerva Neurosciences Inc Stock (NERV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-10-02 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-25 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-09-01 | Eingeleitet | Citigroup | Buy |
| 2017-03-06 | Fortgesetzt | Jefferies | Buy |
| 2016-05-12 | Fortgesetzt | Jefferies | Buy |
Alle ansehen
Minerva Neurosciences Inc Aktie (NERV) Neueste Nachrichten
How risky is Minerva Neurosciences Inc. stock now2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com
Is Minerva Neurosciences Inc. stock ready for a breakout2025 Investor Takeaways & Target Return Focused Picks - newser.com
Will Minerva Neurosciences Inc. stock keep outperforming rivalsMarket Volume Summary & Expert Curated Trade Setups - newser.com
Published on: 2025-11-03 21:39:17 - newser.com
Visualizing Minerva Neurosciences Inc. stock with heatmapsJuly 2025 Review & Weekly High Potential Alerts - newser.com
Is Minerva Neurosciences Inc. (4MNA) stock positioned for secular growthJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com
How buybacks impact Minerva Neurosciences Inc. stock valueMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Technical analysis overview for Minerva Neurosciences Inc. stockJuly 2025 EndofMonth & Real-Time Stock Movement Alerts - newser.com
Using Ichimoku Cloud for Minerva Neurosciences Inc. technicalsMarket Volume Summary & Entry and Exit Point Strategies - newser.com
Is Minerva Neurosciences Inc. stock overvalued by current metrics2025 Market Outlook & Community Verified Trade Alerts - newser.com
Why Minerva Neurosciences Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Will Minerva Neurosciences Inc. stock continue upward momentumMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-03 04:45:50 - newser.com
Will Minerva Neurosciences Inc. stock sustain high P E ratiosJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Will earnings trigger a reversal in Minerva Neurosciences Inc.2025 Big Picture & Fast Gain Swing Alerts - newser.com
Multi asset correlation models including Minerva Neurosciences Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com
What to do if you’re stuck in Minerva Neurosciences Inc.IPO Watch & Accurate Technical Buy Alerts - newser.com
Real time scanner hits for Minerva Neurosciences Inc. explainedWeekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Is Minerva Neurosciences Inc. stock vulnerable to regulatory risksEarnings Performance Report & Weekly Setup with High ROI Potential - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock outperform global peersQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Heatmap analysis for Minerva Neurosciences Inc. and competitorsForecast Cut & High Win Rate Trade Alerts - newser.com
Does Minerva Neurosciences Inc. stock trade at a discount to peers2025 Short Interest & Capital Efficiency Focused Ideas - newser.com
Will Minerva Neurosciences Inc. stock deliver shareholder valueTrade Exit Summary & Weekly High Return Forecasts - newser.com
Analyzing net buyer seller activity in Minerva Neurosciences Inc.2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
Volume spikes in Minerva Neurosciences Inc. stock – what they meanJuly 2025 Summary & Real-Time Market Sentiment Reports - newser.com
Is Minerva Neurosciences Inc. stock attractive for income investorsJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Automated trading signals detected on Minerva Neurosciences Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Combining machine learning predictions for Minerva Neurosciences Inc.Swing Trade & Daily Price Action Insights - newser.com
How interest rate cuts could boost Minerva Neurosciences Inc. stockProfit Target & Risk Managed Investment Strategies - newser.com
Will Minerva Neurosciences Inc. (4MNA) stock extend growth story2025 Dividend Review & Fast Entry Momentum Alerts - newser.com
Visual analytics tools that track Minerva Neurosciences Inc. performanceEntry Point & Safe Capital Investment Plans - newser.com
Minerva Neurosciences Inc. recovery potential after sell offJuly 2025 Breakouts & Daily Technical Stock Forecast Reports - newser.com
Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):